IDWeek 2021

AWG Member Company Participation at IDWeek 2021

10 AWG member companies will present data from their clinical and research programs at the virtual IDWeek 2021 held September 29 – October 3, with a total of 23 posters and three oral abstracts.

IDWeek is the joint annual meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP) that brings together infectious disease professionals to present and discuss the latest approaches in prevention, diagnosis, treatment, and epidemiology of infectious diseases.

 

A1. Novel Agents
Session: Novel Antimicrobial Agents
Oral Abstract

Venatorx Pharmaceuticals :

 

A1. Novel Agents
Poster Session: Novel Agents

Summit Therapeutics:

Qpex Biopharma:

Venatorx Pharmaceuticals:

Iterum Therapeutics

Entasis Therapeutics:

Cidara Therapeutics:

Paratek Pharmaceuticals:

 

A3. Resistance Mechanisms
Poster Session: Resistance Mechanisms

Venatorx Pharmaceuticals:

 

A4. Treatment of antimicrobial resistant infections
Session: What’s New in Antimicrobial Resistance
Oral Abstract

Venatorx Pharmaceuticals:

 

A4. Treatment of antimicrobial resistant infections
Poster Session: Resistance Mechanisms

Venatorx Pharmaceuticals:

 

A6. New Drug Development
Poster Session: New Drug Development

Paratek Pharmaceuticals:


C3. Skin and Soft Tissue
Poster Session: Skin and Soft Tissue

Paratek Pharmaceuticals:


C5. Respiratory Infections – Bacterial
Poster Session: Respiratory Infections – Bacterial

Nabriva Therapeutics:

 

C6. Enteric Infection
Poster Session: Enteric Infection

Acurx Pharmaceuticals:

 

Session D1. Diagnostics: Bacteriology/mycobacteriology
Poster Session: Diagnostics: Bacteriology/mycobacteriology 

Venatorx Pharmaceuticals:

 

M1. Clinical studies of fungal infections
Session: New Findings in Medical Mycology
Oral Abstract

SCYNEXIS

 

M1. Clinical studies of fungal infections
Poster Session: Medical Mycology

Cidara Therapeutics:

SCYNEXIS:

 

N8. Health Care-Associated Infections: C. difficile
Poster Session: HAI: C. difficile

Paratek Pharmaceuticals:

 

N10. Healthcare-Associated Infections: Gram-Negatives (MDR-GNR)
Poster Session: HAI: Gram-negatives (MDR-GNR)

Venatorx Pharmaceuticals:

 

O. Public Health
Poster Session: Public Health

Paratek Pharmaceuticals:

 

S6. Antibiotic Stewardship: Trends in Antimicrobial Prescribing
Poster Session: Antimicrobial Stewardship: Trends in Antimicrobial Prescribing

Cidara Therapeutics: